These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6135686)

  • 1. Study of alanine aminopeptidase excretion as a test of gentamicin nephrotoxicity.
    Davey PG; Geddes AM; Cowley DM
    J Antimicrob Chemother; 1983 May; 11(5):455-65. PubMed ID: 6135686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides.
    Motuz DJ; Watson WA; Barlow JC; Velasquez NV; Schentag JJ
    Anesth Analg; 1988 Aug; 67(8):770-4. PubMed ID: 2899408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin.
    Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC
    Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin.
    Rybak MJ; Frankowski JJ; Edwards DJ; Albrecht LM
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1461-4. PubMed ID: 2893584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity.
    Whiting PH; Brown PA
    Ren Fail; 1996 Nov; 18(6):899-909. PubMed ID: 8948524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
    Trollfors B; Bergmark J; Hiesche K; Jagenburg R
    Infection; 1984; 12(1):20-2. PubMed ID: 6142864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers.
    Chapelsky MC; Nix DE; Cavanaugh JC; Wilton JH; Norman A; Schentag JJ
    Drug Saf; 1992; 7(4):304-9. PubMed ID: 1355971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrononephrotoxicity in rat of a vancomycin and gentamicin combination.
    Fauconneau B; De Lemos E; Pariat C; Bouquet S; Courtois P; Piriou A
    Pharmacol Toxicol; 1992 Jul; 71(1):31-6. PubMed ID: 1355906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymuria in neonates receiving continuous intravenous infusion of gentamicin.
    Colding H; Brygge K; Brendstrup L; Bentzon MW; Andersen GE
    APMIS; 1992 Feb; 100(2):119-24. PubMed ID: 1348177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
    Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
    Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteers.
    Kazierad DJ; Wojcik GJ; Nix DE; Goldfarb AL; Schentag JJ
    J Clin Pharmacol; 1995 Feb; 35(2):196-201. PubMed ID: 7751432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variations in the renal toxicity of gentamicin in rats.
    Pariat C; Courtois P; Cambar J; Piriou A; Bouquet S
    Toxicol Lett; 1988 Feb; 40(2):175-82. PubMed ID: 2893472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of beta 2-microglobulin, muramidase, and alanine aminopeptidase as markers of gentamicin nephrotoxicity.
    Davey PG; Cowley DM; Geddes AM; Terry J
    Contrib Nephrol; 1984; 42():100-6. PubMed ID: 6152413
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).
    Wiecek A; Kokot F; Grzeszczak W
    Int Urol Nephrol; 1988; 20(5):461-70. PubMed ID: 2906920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Kuhlmann J; Seidel G; Grötsch H
    Infection; 1982; 10(4):233-9. PubMed ID: 6127319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
    Hsu WS; Kao JT; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infradian rhythms of alanine aminopeptidase excretion during gentamicin therapy.
    Balschun D; Burchardt U; Klagge M; Stein W
    Eur J Clin Chem Clin Biochem; 1991 Dec; 29(12):783-6. PubMed ID: 1686729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic renal tubular effects in relation to urine cadmium levels.
    Mueller PW; Smith SJ; Steinberg KK; Thun MJ
    Nephron; 1989; 52(1):45-54. PubMed ID: 2565539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subtotal nephrectomy on the excretion of urinary alanine aminopeptidase and gamma glutamyltransferase in the male Wistar rat. A long-term study.
    Stoykova S; Philippon C; Labaille F; Prevot D; Mondorf AW; Manuel Y
    Ren Physiol; 1984; 7(3):156-62. PubMed ID: 6146167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP)].
    Bertotti A; De Marchi S; Brovedani P; Gaeta G; Peratoner L; Mangiarotti MA
    Pediatr Med Chir; 1990; 12(4):347-9. PubMed ID: 1981610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.